What Researchers Did
Researchers reviewed the latest science on why post-concussion symptoms last for months or years after a mild head injury, and examined emerging treatments including hyperbaric oxygen therapy (HBOT).
What They Found
Persistent post-concussion syndrome (PCS) involves measurable brain changes visible on advanced imaging, along with identifiable biological markers in the blood. Current standard treatments have limited success. Evidence reviewed suggests HBOT, along with neuromodulation and targeted therapies, may address the underlying brain damage rather than just masking symptoms.
What This Means for Canadian Patients
Hundreds of thousands of Canadians sustain concussions each year, and up to 30% develop persistent symptoms that affect work, school, and daily life. This review supports a shift toward personalized treatment plans that combine HBOT with other therapies for people whose symptoms do not improve after standard care.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a review article, not a clinical trial, so it summarizes existing evidence rather than producing new patient outcome data.